Revolution Medicines Inc (RVMD)

Finanzdaten der Revolution Medicines Inc-Aktie (RVMD)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.742	-	3.824	7.014	15.33
Operating Expenses	46.64% 180.72	123.25	112.62	82.17	77.04
Benefits Costs and Expenses	44.20% 161.94	112.30	102.12	75.11	71.96
Costs And Expenses	44.20% 161.94	112.30	102.12	75.11	71.96
Operating Income/Loss	46.03% -179.98	-123.25	-108.80	-75.16	-61.71
Nonoperating Income/Loss	71.64% 18.79	10.95	10.50	7.059	5.077
Income/Loss From Continuing Operations Before Tax	43.54% -161.19	-112.30	-98.30	-68.10	-56.63
Income Tax Expense/Benefit	108.87% 0.343	-3.867	-	-	-0.123
Income/Loss From Continuing Operations After Tax	48.97% -161.54	-108.43	-98.30	-68.10	-56.51
Net Income/Loss	48.97% -161.54	-108.43	-98.30	-68.10	-56.51
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	91.35% 9.4474	109.23	106.88	94.83	2.8753
Diluted Average Shares	91.35% 9.4474	109.23	106.88	94.83	2.8753
Basic Earnings Per Share	22.22% -1.21	-0.99	-0.92	-0.72	-0.61
Diluted Earnings Per Share	22.22% -1.21	-0.99	-0.92	-0.72	-0.61
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-